2025-12-17 - Analysis Report
Okay, let's break down the analysis of UnitedHealth Group (UNH) based on the provided data.

**0) Overview and Structure**

This report presents a detailed analysis of UNH stock, covering performance, technical indicators, recent news, analyst opinions, earnings, and financial information.  We'll start with the raw numbers and then provide some simple interpretations.

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **UNH Overview:** UnitedHealth Group Inc. is a diversified health care company.

*   **Return Rates:**
    *   UNH Cumulative Return: -16.71%
    *   S&P 500 (VOO) Cumulative Return: 99.81%

*   **Divergence:**
    *   Current Divergence: -120.5
    *   Divergence Range: -130.7 to 36.3
    *   Relative Divergence: 6.1

*   **Analysis:** UNH has significantly underperformed the S&P 500.  The divergence is currently near the lower end of its historical range. The negative relative divergence indicates that UNH is performing relatively worse than it has in the past compared to the S&P 500.

*   **Alpha, Beta, CAGR, MDD Analysis Table:**

    | Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
    |------------|----------|----------|---------|--------|--------|
    | 2015-2017  | 58.0%    | 66.4%    | 30.0%   | 0.1    | 199.7  |
    | 2016-2018  | 41.0%    | 70.4%    | 26.0%   | 0.1    | 225.7  |
    | 2017-2019  | 36.0%    | 73.8%    | 14.0%   | 0.2    | 266.3  |
    | 2018-2020  | -43.0%   | 81.2%    | -67.0%  | 0.5    | 317.7  |
    | 2019-2021  | 16.0%    | 81.2%    | -30.0%  | 1.5    | 454.9  |
    | 2020-2022  | -1.0%    | 81.2%    | 0.0%    | 1.5    | 480.3  |
    | 2021-2023  | 24.0%    | 80.8%    | 23.0%   | 0.4    | 476.9  |
    | 2022-2024  | -27.0%   | 78.8%    | -47.0%  | 0.3    | 458.2  |
    | 2023-2025  | -59.0%   | 79.8%    | -123.0% | 1.2    | 302.7  |

*   **Analysis of Table:**
    *   **CAGR (Compound Annual Growth Rate):** The CAGR has declined significantly, with recent periods showing negative growth.
    *   **MDD (Maximum Drawdown):** The MDD is consistently high, indicating significant potential for loss.
    *   **Alpha:**  Alpha has turned negative in recent periods, suggesting underperformance relative to its risk (Beta).  The most recent period shows a very large negative alpha.
    *   **Beta:** Beta fluctuates, but is elevated in 2019-2021, 2020-2022 and 2023-2025 periods, showing high volatilities.
    *   **Cap(B):** The Market Cap has decreased in the last time period.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 334.20
*   **Previous Close:** 341.1
*   **Change:** -2.02%
*   **5-day SMA:** 336.45
*   **20-day SMA:** 327.34
*   **60-day SMA:** 341.11

*   **Analysis:** The stock price is currently below its 5-day and 60-day moving averages but above its 20-day moving average. This suggests a short-term downward trend, but it could be stabilizing above the 20-day SMA.  The negative change from the previous close confirms recent downward pressure.

**3) RSI, PPO, MRI, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommended)
*   **RSI:** 55.99
*   **PPO:** 0.5984
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21 (Cash Ratio: 0% on 2025-12-08)
*   **Recent (20 days) relative divergence change:** -2.0 (Negative - short-term decline)
*   **Expected Return (%):** -304.8%

*   **Analysis:**
    *   The MRI suggests a medium investment recommendation.
    *   The RSI is around 56, suggesting a neutral condition (not overbought or oversold).
    *   The PPO being positive indicates a slight upward trend, but it's relatively small.
    *   The Hybrid Signal suggests a 90% buy using available cash, but this is tempered by the "Safe" classification and the MRI within the signal.
    *   The negative change in relative divergence indicates recent underperformance.
    *   The significantly negative Expected Return is a major red flag, suggesting the model predicts substantial losses relative to the S&P 500 in the long term.

**4) Recent News & Significant Events**

*   **Key Headlines (summarized):**
    *   Analyst Forecasts and Investor Sentiment
    *   Potential Catalysts for Growth
    *   Stock Price Down 2%
    *   Long-Term Investment Performance
    *   Most Negatives Priced In, Transition Year Expected in 2026
    *   Reason for Stock Price Increase

*   **Analysis:** The news is mixed. While some articles discuss potential catalysts and long-term performance, others highlight recent price declines. The headline suggesting that negatives are priced in and 2026 could be a transition year is potentially positive, but it also implies challenges in the near term.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~1.96)
*   **Number of Opinions:** 25
*   **Target Price:** Average: 392.24 / High: 440.00 / Low: 280.00
*   **Recent Rating Changes:** Not specified (indicated by empty parentheses).

*   **Analysis:** Analysts, on average, have a "Buy" rating on UNH. The average target price is significantly higher than the current price, suggesting potential upside. However, the wide range between the high and low target prices indicates some uncertainty among analysts. The lack of recent rating changes makes it difficult to know if analysts are revising their opinions based on recent performance.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9  | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

*   **Analysis:**
    *   **EPS (Earnings Per Share):** EPS has fluctuated.
    *   **Revenue:** Revenue has generally increased.

**6) Financial Information: Revenue, Profitability, Capital, and ROE**

*   **Revenue and Profitability:**

    | Quarter      | Revenue    | Profit Margin |
    |--------------|------------|---------------|
    | 2025-09-30   | $113.16B   | 18.24%        |
    | 2025-06-30   | $111.62B   | 17.93%        |
    | 2025-03-31   | $109.58B   | 21.70%        |
    | 2024-12-31   | $100.81B   | 21.14%        |
    | 2024-09-30   | $100.82B   | 22.84%        |

*   **Capital and Profitability:**

    | Quarter      | Equity     | ROE     |
    |--------------|------------|---------|
    | 2025-09-30   | $95.79B   | 2.45%   |
    | 2025-06-30   | $94.72B   | 3.60%   |
    | 2025-03-31   | $95.04B   | 6.62%   |
    | 2024-12-31   | $92.66B   | 5.98%   |
    | 2024-09-30   | $94.53B   | 6.41%   |

*   **Analysis:**
    *   **Revenue:** Revenue is growing steadily.
    *   **Profit Margin:** Profit margins have decreased recently.
    *   **Equity:** Equity is relatively stable.
    *   **ROE (Return on Equity):** ROE has decreased, which aligns with the decline in profit margins.

**7) Comprehensive Analysis (Summary)**

Overall, the analysis paints a mixed picture of UNH.

*   **Negatives:**
    *   Significant underperformance compared to the S&P 500.
    *   Negative expected return.
    *   Declining profit margins and ROE.
    *   Mixed news sentiment with an emphasis on recent price declines.
    *   Relatively high MDD and elevated Beta.

*   **Positives:**
    *   Growing revenue.
    *   Analyst consensus is "Buy" with a significant upside target price.
    *   Hybrid Signal suggesting a buying opportunity
    *   Market Risk Indicator (MRI) suggests a medium investment recommendation.
    *   Some news suggesting that negatives may be priced in.

*   **Conclusion:**

    Based on the current data, UNH appears to be facing challenges. The negative expected return and underperformance relative to the S&P 500 are significant concerns. However, the analyst ratings and potential for a turnaround in 2026 suggest that the stock may have some potential. Investors should carefully consider these factors and do further research before making any investment decisions. The analyst target price being significantly higher than the current price suggests optimism from that side.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.